Hypoxemia Clinical Trial
Official title:
A Randomised Control Trial to Determine Whether Intervention Based on a Microstream Capnography-based Ventilation Monitoring System Will Decrease Hypoxaemaia During Intravenous Sedation With Midazolam.
Dentists use sedation to help patients accept difficult procedures and to relieve anxiety. During sedation, the well-being of the patient is monitored by the dental team. When carried out according to recognised guidelines,intravenous dental sedation is considered to be very safe. For some patients, dental sedation is a useful alternative to general anaesthetic. It is cheaper and has the potential to be more accessible. Oximetry(measurement of oxygen status) is the current gold standard in dental sedation. The main risk to the patient during sedation is a slowing of breathing due to the effects of the sedative drug. Studies from other settings where sedation is practiced suggest that an additional monitor with capnography facilitates early detection of depressed breathing. However, the results of studies from other medical settings cannot be generalised to dental sedation, because of different techniques used and the types of patients. The depth of sedation may also be vary. For dental sedation, patients remain responsive at all times and breathe for themselves. Capnography gives breath by breath information using a simple device placed close to the nose and mouth. It has been recommended by several governing medical bodies that each area of medicine, should develop its own guidelines for sedation. Therefore, there is a need to research the application of capnography for dental sedation. The proposed study will take place at a university hospital site. Patients will be randomly divided into two groups. Both groups will receive sedation in the normal way. The study group will have capnography monitoring added. The study will look for differences in breathing between the two groups. Additional information regarding other aspects of monitoring will also be obtained. The results from the proposed study may help to improve patient safety and change current practice during sedation for dentistry.
Background Intravenous sedation allows procedures to be performed in dentistry, and other
areas of medicine beyond the operating room. Its application in each area is tailored to the
requirements of the relevant procedure, the setting and the levels of operator training and
expertise. The Academy of Medical Royal Colleges emphasises that each speciality must
produce its own form of guidance in the use of sedative techniques. The following definition
for conscious sedation in dentistry is accepted by the General Dental Council and the Dental
Sedation Teachers Group: "A technique in which the use of a drug or drugs produces a state
of depression of the central nervous system enabling treatment to be carried out, but during
which verbal contact with the patient is maintained throughout the period of sedation. The
drugs and techniques used to provide conscious sedation for dental treatment should carry a
margin of safety wide enough to render loss of consciousness unlikely". The Standing Dental
Advisory Committee Guidance 2003, which remains the standard of guidance in the UK, further
states: "Any technique resulting in the loss of consciousness is defined as general
anaesthesia and in the UKm 'deep sedation' is considered within this category". To
summarise; dental sedation lies within the range of minimal to moderate sedation on the
sedation continuum i.e. conscious sedation. Deep sedation is to be avoided in this setting.
Dentists who have completed a recognised postgraduate course can practice conscious sedation
independently. For intravenous sedation, dentists use a "standard" conscious sedation
technique, defined as "intravenous sedation", using midazolam alone. The drug is titrated to
an end-point; it is rapid in onset and possesses a short duration of action, which means
that midazolam is very useful in the field of dental sedation.
The current standard of monitoring for patients is clinical monitoring, which must be
supplemented by pulse oximetry and blood pressure readings. The most important side effect
of midazolam is respiratory depression.
Although it is generally considered a safe practice, conscious sedation is not entirely
risk-free.Ventilation (breathing) and oxygenation are related but seperate physiological
processes. During the process of sedation, clinicians rely on pulse oximetry as a surrogate
measure of ventilation. Capnography, a staple gold standard in general anaesthesia, is
becoming an increasingly important area of interest for procedural sedation, with studies
from other settings suggesting, capnography to be an effective ventilatory monitor for
sedated patients.
One significant limitation of pulse oximetry is the lag time; this means that the partial
pressure of oxygen may decrease significantly before the pulse oximeter signals the fall.
Reviewing the literature Previous studies on capnography for sedation are difficult to
summarise. A review of the available literature has shown a relative paucity of randomised
trials and no trials in the dental setting. Three trials from other settings are summarised
here. Beitz et al (2012): A total of 760 patients were enrolled. Patients received 2L/min of
supplemental oxygen. The intention-to-treat analysis revealed a significant reduction in the
incidence of oxygen desaturation in the capnography arm in comparison with the conventional
arm (38.9% vs. 53.2%). The study conclusion was that additional capnography monitoring
reduces the incidence of oxygen desaturation and hypoxemia during propofol sedation for
colonoscopy. Deitch et al (2010): A total of 132 patients in an emergency room setting.
Hypoxia was defined as an SpO2 < 93%. The incidence of oxygen desaturation in the
capnography arm in comparison with the conventional arm was 25% vs. 42%. All patients
received supplemental oxygen (3L/minute). Conclusion: The addition of capnography to
standard monitoring reduced the incidence of hypoxia and provided advanced warning for all
hypoxic events. Qadeer et al (2009):This trial showed a significantly reduced rate of
hypoxia (46% vs 69%), defined as an oximetry reading < 90% for 15 sec. There was a
relatively large cohort of ASA 3 patients in the study. 147 patients received supplemental
oxygen. The study conclusion was that capnography monitoring of respiratory activity
improves patient safety during procedural sedation for elective endoscopy.
Waugh et al (2010) conducted a meta - analysis, the main finding being that during
procedural sedation , cases of respiratory depression were 17.6 times more likely to be
detected if monitored by capnography than cases not monitored by capnography ( 95% CI,
2.5-122.1).
The results from the three randomised trials and the meta-analysis cannot be generalised and
extrapolated to the standard dental sedation technique because of:
1. Different patient populations The reviewed studies contain many elderly patients who
are known to be more sensitive to sedative drugs and more likely to have co -
morbidities. For standard dental sedation the age is less than 65 years.
2. Supplemental Oxygen In standard dental technique patients breath room air. In the
reviewed studies supplemental oxygen was often administered.
3. Drugs Different drugs were used to achieve sedation in the reviewed studies e.g.
Propofol and Ketamine.
4. Analgesia Local anaesthetic is employed for analgesia in dentistry. In the reviewed
studies, analgesia was often achieved with the use of intravenous agents such as
opioids. The synergistic effect of drugs used in combination are likely to have
resulted in increased respiratory depression.
5. Desaturation (SpO2) For the standard dental sedation technique an SpO2< 95% is regarded
as the threshold for early desaturation.This is a reasonable threshold in this setting
where sedation is administered by a non-anaesthetist outside of the operating room. In
the reviewed studies the thresholds varied. Deitch et al used a threshold < 93% and
Qadeer et al. <90%.
6. Depth of sedation Varied between the studies and in some cases was beyond conscious
sedation.
Aim:
The aim of this randomized, controlled study is to determine whether early intervention
based upon data from capnographic monitoring reduces the incidence of arterial oxygen
desaturation during midazolam sedation for dentistry.
Objectives:
1. Determine if early intervention based on capnography will influence the incidence of
arterial oxygen desaturation.
2. Characterise the ETCO2, respiratory rate and SPO2 at baseline pre sedation, during
sedation and post sedation.
This will be a prospective, randomised controlled trial on dental patients receiving
intravenous conscious sedation with midazolam.
Goal: To determine whether use by the dental team of real - time capnography is associated
with a decrease in the incidence of oxygen desaturation (hypoxia) compared with standard
monitoring alone during intravenous sedation with midazolam for dentistry.
Setting and selection of participants:
Patients attending the oral surgery department and the dental theatre for sedation
procedures at Cork University dentalo school and Hospital and Cork University Hospital will
be prospectively invited to take part. Patients will be randomly assigned to the study group
(standard monitoring and capnography) or control group (standard monitoring and blinded
capnography) . The sedation team will be blinded to the randomisation choice until after
enrolment. A member of staff not directly involved in the study will conduct the
randomisation. There is evidence for utilising intravenous midazolam in the age group 14 to
16years (post pubertal) for dentistry. Including this age cohort ( with parental consent)
will provide additional research data to add to the body of evidence. Patients will have
intravenous sedation with midazolam primarily for the relief of anxiety and to help them to
accept invasive procedures. The operative procedures will range from simple extractions to
minor oral surgery procedures such as the removal of impacted wisdom teeth.
Pre sedation visit:
Patients will be assessed as to their suitability for sedation at a separate pre sedation
visit Baseline capnography and pulse oximetry data will be collected at this visit. Patients
meeting the inclusion criteria will be given written information about the study. This
information will be written in lay language.
Enrolment to the study will take place at the beginning of the subsequent treatment visit
for those patients who consent to take part having had time to consider the information
provided about the study at the pre assessment visit. Patients will receive pre sedation
instructions. Standard electronic monitoring (pulse oximetry, pulse rate and blood pressure)
will be available to the clinical staff at all times. Standard dental sedation will be used
according to the institutions policy and protocol. A capnostream 20 monitor ( Oridian
medical, Needham, MA), using a disposable oral - nasal CO2 cannula capable of delivering
oxygen, with an oral sampling port to accommodate mouth breathing will be attached to all
patients. The capnostream 20 monitor displays oximetry and CO2 waveform and calculates
ETCO2. The capnography monitor will be calibrated every day of the study.
Continuous recording of SpO2, Heart rate, ETCO2 and respiratory rate will be stored on a
laptop computer via specialised software for post hoc analysis. In addition, clinical staff
will keep paper records of the patients' age, sex, body mass index, ASA status and medical
history. All patients will be assigned a code to maintain confidentiality.
Before the study, all clinicians and nursing staff will be trained in the interpretation of
capnography in relation to respiratory depression including waveform interpretation. A
laminated interpretation card will be attached to the monitor as a reminder. The sedation
team will perform conscious sedation according to standard protocol for dental sedation.
Intervention for an adverse event will be based on judgement and clinician expertise with or
without capnography depending on randomisation arm. In the capnography arm,in addition to
standard monitoring, changes in the shape of the capnography waveform, ETCO2 numeric changes
will be considered as triggers to take measures to avoid desaturation. In the control group,
capnography will be blinded by placing an opaque screen over the capnostream 20
capnographydisplay of ETCO2 values, respiratory rate and waveform. Pulse oximetry will
continue to be displayed. Baseline monitoring data will be obtained for at least 2 minutes
prior to the first infusion. Midazolam will be titrated at a rate of one mg per minute to an
end point. Most patients are discharged 60 minutes after the last increment provided they
are fit for discharge. We propose collecting study data until discharge.
All patients will receive written pre and post sedation instructions. the benzodiazepine
antagonist , flumazenil will be available in the sedation suite at all times in addition to
emergency drugs and equipment.
The Null hypothesis states: The study group is the same or equal to the control group in
terms of hypoxemia rates i.e arterial oxygen desaturation.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT03628560 -
Alternate Methodology of Pulse Oximeter Validation
|
N/A | |
Completed |
NCT02866578 -
Open Lung Protective Ventilation in Cardiac Surgery
|
N/A | |
Recruiting |
NCT06139081 -
Oxygen Delivery Methods of Nasal Catheter on the Incidence of Hypoxemia in Patients With Painless Gastroscopy
|
N/A | |
Not yet recruiting |
NCT05964309 -
Pre-oxygenation in Sitting Position and Oxygen Reserve Index
|
N/A | |
Completed |
NCT00675415 -
Does Capnography Prevent Hypoxemia During Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound?
|
N/A | |
Completed |
NCT00740220 -
Reproducibility of 6 Minute Walk Tests for Oxygen Desaturation
|
N/A | |
Completed |
NCT04557605 -
Effects of a Face Mask on Oxygenation During Exercise
|
N/A | |
Active, not recruiting |
NCT05479929 -
Work of Breathing Assessment in Triage Scale
|
||
Recruiting |
NCT05422430 -
Rebreathing-induced Hypoxia and Glucose Levels
|
N/A | |
Recruiting |
NCT03009643 -
Salvage Treatment of Inhaled Nitric Oxide in Patients With Refractory Hypoxemia After Aortic Surgery
|
N/A | |
Completed |
NCT01477450 -
Comparison of Oxygen Delivery Devices for Reversal of Altitude-Induced Hypoxemia in Normal Subjects
|
N/A | |
Completed |
NCT01470170 -
Regimen of Alfentanil in Propofol Sedative Fibro-bronchoscopy
|
Phase 4 | |
Recruiting |
NCT06085859 -
Anesthesia Endoscope Mask is Applied to Sedation Upper Gastrointestinal Endoscopic Diagnosis and Treatment
|
N/A | |
Recruiting |
NCT03969615 -
SuperNO2VA™ and General Anesthesia Postoperative Care
|
N/A | |
Completed |
NCT02554110 -
Peripheral Nerve Stimulation to Reduce Hypoxic Events
|
N/A | |
Completed |
NCT04998253 -
Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2
|
Early Phase 1 | |
Completed |
NCT04566419 -
poStoperative Anesthesia Care: Facial Mask vs Hfnc and Thoracic Ultrasound for Reduction of Atelectasis Incidence
|
N/A | |
Recruiting |
NCT04079465 -
Automated Oxygen Control by O2matic to Patients Admitted With Acute Hypoxemia
|
N/A | |
Recruiting |
NCT06022523 -
Accuracy of Pulse Oximeters With Profound Hypoxia
|
N/A | |
Completed |
NCT04159116 -
Prevention and Treatment of Laryngospasm and Hypoxemia Based on Risk Factors in Adult Outpatients Undergoing EGD
|
N/A |